Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Fatigue 1

Interventions

Cytarabine 899Cyclophosphamide 894fludarabine 517venetoclax 475fludarabine phosphate 464Azacitidine 452Rituximab 418Methotrexate 415Etoposide 319Filgrastim 299Busulfan 295Dexamethasone 285Vincristine 281Daunorubicin 280Peripheral Blood Stem Cell Transplantation 257Whole-Body Irradiation 240Mycophenolic Acid 231Decitabine 228Granulocyte Colony-Stimulating Factor 225Tacrolimus 219Idarubicin 203Melphalan 201Imatinib Mesylate 195Cyclosporine 182Doxorubicin 177Radiotherapy 169Prednisone 161Mitoxantrone 160Lenalidomide 159Mercaptopurine 155

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × AIEOP acute lymphoblastic leukemia protocol × Other hematologic neoplasm × Clear all
NCT06184009 2025-06-08

HR ALL

Seoul St. Mary's Hospital

Phase 2 Recruiting
370 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04406285 2020-05-28

Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent.

Federal University of Health Science of Porto Alegre

Phase NA Unknown
66 enrolled
LymphoidOther hematologic neoplasm

Fatigue, Leukemia, Lymphoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡